|
|
||||||||

ler



,

Divisions of
*
Hematology and Oncology and
Dermatology, Department of Medicine, and
Department of Microbiology and Immunology, University of California, Los Angeles, School of Medicine, Los Angeles, CA 90095;
Institut für Klinische Mikrobiologie, Immunologie und Hygiene, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany;
¶
Department of Pediatrics, Stanford University, Stanford, CA 94305; and
||
Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461
Human NKT cells are a unique subset of T cells that express an invariant V
24 TCR that recognizes the nonclassical Ag-presenting molecule CD1d. Activation of NKT cells is greatly augmented by the marine sponge-derived glycolipid
-galactosylceramide (
GalCer). Because human monocyte-derived cells express CD1d and can harbor the intracellular pathogen Mycobacterium tuberculosis, we asked whether the addition of
GalCer could be used to induce effector functions of NKT cells against infected monocytes, macrophages, and monocyte-derived dendritic cells. NKT cells secreted IFN-
, proliferated, and exerted lytic activity in response to
GalCer-pulsed monocyte-derived cells. Importantly,
GalCer-activated NKT cells restricted the growth of intracellular M. tuberculosis in a CD1d-dependent manner. NKT cells that exhibited antimycobacterial activity also expressed granulysin, an antimicrobial peptide shown to mediate an antimycobacterial activity through perturbation of the mycobacterial surface. Degranulation of NKT cells resulted in depletion of granulysin and abrogation of antimycobacterial activity. The detection of CD1d in granulomas of tuberculosis patients supports the potential interaction of NKT cells with CD1d-expressing cells at the site of disease activity. These studies provide evidence that
GalCer-activated CD1d-restricted T cells can participate in human host defense against M. tuberculosis infection.
This article has been cited by other articles:
![]() |
B. Rivas-Santiago, C. J. Serrano, and J. A. Enciso-Moreno Susceptibility to Infectious Diseases Based on Antimicrobial Peptide Production Infect. Immun., November 1, 2009; 77(11): 4690 - 4695. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Walch, S. K. Rampini, I. Stoeckli, S. Latinovic-Golic, C. Dumrese, H. Sundstrom, A. Vogetseder, J. Marino, D. L. Glauser, M. van den Broek, et al. Involvement of CD252 (CD134L) and IL-2 in the Expression of Cytotoxic Proteins in Bacterial- or Viral-Activated Human T Cells J. Immunol., June 15, 2009; 182(12): 7569 - 7579. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rahman, B. Gudetta, J. Fink, A. Granath, S. Ashenafi, A. Aseffa, M. Derbew, M. Svensson, J. Andersson, and S. G. Brighenti Compartmentalization of Immune Responses in Human Tuberculosis: Few CD8+ Effector T Cells but Elevated Levels of FoxP3+ Regulatory T Cells in the Granulomatous Lesions Am. J. Pathol., June 1, 2009; 174(6): 2211 - 2224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bastian, T. Braun, H. Bruns, M. Rollinghoff, and S. Stenger Mycobacterial Lipopeptides Elicit CD4+ CTLs in Mycobacterium tuberculosis-Infected Humans J. Immunol., March 1, 2008; 180(5): 3436 - 3446. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Andersson, A. Samarina, J. Fink, S. Rahman, and S. Grundstrom Impaired Expression of Perforin and Granulysin in CD8+ T Cells at the Site of Infection in Human Chronic Pulmonary Tuberculosis Infect. Immun., November 1, 2007; 75(11): 5210 - 5222. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Korosec, K. Osolnik, I. Kern, M. Silar, K. Mohorcic, and M. Kosnik Expansion of Pulmonary CD8+CD56+ Natural Killer T-Cells in Hypersensitivity Pneumonitis Chest, October 1, 2007; 132(4): 1291 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Huang, S.-C. Lyu, C. Clayberger, and A. M. Krensky Granulysin-Mediated Tumor Rejection in Transgenic Mice J. Immunol., January 1, 2007; 178(1): 77 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Im, N. Tapinos, G.-T. Chae, P. A. Illarionov, G. S. Besra, G. H. DeVries, R. L. Modlin, P. A. Sieling, A. Rambukkana, and S. A. Porcelli Expression of CD1d Molecules by Human Schwann Cells and Potential Interactions with Immunoregulatory Invariant NK T Cells J. Immunol., October 15, 2006; 177(8): 5226 - 5235. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Brutkiewicz CD1d Ligands: The Good, the Bad, and the Ugly J. Immunol., July 15, 2006; 177(2): 769 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stegelmann, M. Bastian, K. Swoboda, R. Bhat, V. Kiessler, A. M. Krensky, M. Roellinghoff, R. L. Modlin, and S. Stenger Coordinate Expression of CC Chemokine Ligand 5, Granulysin, and Perforin in CD8+ T Cells Provides a Host Defense Mechanism against Mycobacterium tuberculosis J. Immunol., December 1, 2005; 175(11): 7474 - 7483. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Patton, T. C. McGuire, M. T. Hines, R. H. Mealey, and S. A. Hines Rhodococcus equi-Specific Cytotoxic T Lymphocytes in Immune Horses and Development in Asymptomatic Foals Infect. Immun., April 1, 2005; 73(4): 2083 - 2093. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Buettner, C. Meinken, M. Bastian, R. Bhat, E. Stossel, G. Faller, G. Cianciolo, J. Ficker, M. Wagner, M. Rollinghoff, et al. Inverse Correlation of Maturity and Antibacterial Activity in Human Dendritic Cells J. Immunol., April 1, 2005; 174(7): 4203 - 4209. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Walch, E. Eppler, C. Dumrese, H. Barman, P. Groscurth, and U. Ziegler Uptake of Granulysin via Lipid Rafts Leads to Lysis of Intracellular Listeria innocua J. Immunol., April 1, 2005; 174(7): 4220 - 4227. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Patton, T. C. McGuire, D. G. Fraser, and S. A. Hines Rhodococcus equi-Infected Macrophages Are Recognized and Killed by CD8+ T Lymphocytes in a Major Histocompatibility Complex Class I-Unrestricted Fashion Infect. Immun., December 1, 2004; 72(12): 7073 - 7083. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Levy Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes J. Leukoc. Biol., November 1, 2004; 76(5): 909 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Endsley, J. L. Furrer, M. A. Endsley, M. A. McIntosh, A. C. Maue, W. R. Waters, D. R. Lee, and D. M. Estes Characterization of Bovine Homologues of Granulysin and NK-lysin J. Immunol., August 15, 2004; 173(4): 2607 - 2614. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Plackett, E. D. Boehmer, D. E. Faunce, and E. J. Kovacs Aging and innate immune cells J. Leukoc. Biol., August 1, 2004; 76(2): 291 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Hagge, N. A. Ray, J. L. Krahenbuhl, and L. B. Adams An In Vitro Model for the Lepromatous Leprosy Granuloma: Fate of Mycobacterium leprae from Target Macrophages after Interaction with Normal and Activated Effector Macrophages J. Immunol., June 15, 2004; 172(12): 7771 - 7779. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Skold and S. M. Behar Role of CD1d-Restricted NKT Cells in Microbial Immunity Infect. Immun., October 1, 2003; 71(10): 5447 - 5455. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |